Distinct Phosphotyrosine-dependent Functions of the ShcA Adaptor Protein Are Required for Transforming Growth Factor β (TGFβ)-induced Breast Cancer Cell Migration, Invasion, and Metastasis*

Background: ShcA integrates TGFβ and ErbB2 signaling in breast cancer. Results: Distinct motifs within ShcA facilitate TGFβ-induced effects in ErbB2-expressing cells. Conclusion: ShcA transduces distinct signals via Grb2 downstream of Tyr313 and Crk adaptors downstream of Tyr239/Tyr240, and all three residues are required for metastasis. Significance: ShcA is essential for the tumorigenesis and metastasis of ErbB2-expressing breast tumors with active TGFβ signaling. The ErbB2 and TGFβ signaling pathways cooperate to promote the migratory, invasive, and metastatic behavior of breast cancer cells. We previously demonstrated that ShcA is necessary for these synergistic interactions. Through a structure/function approach, we now show that the phosphotyrosine-binding, but not the Src homology 2, domain of ShcA is required for TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells. We further demonstrate that the tyrosine phosphorylation sites within ShcA (Tyr239/Tyr240 and Tyr313) transduce distinct and non-redundant signals that promote these TGFβ-mediated effects. We demonstrate that Grb2 is required specifically downstream of Tyr313, whereas the Tyr239/Tyr240 phosphorylation sites require the Crk adaptor proteins to augment TGFβ-induced migration and invasion. Furthermore, ShcA Tyr313 phosphorylation enhances tumor cell survival, and ShcA Tyr239/Tyr240 signaling promotes endothelial cell recruitment into ErbB2-expressing breast tumors in vivo, whereas all three ShcA tyrosine residues are required for efficient breast cancer metastasis to the lungs. Our data uncover a novel ShcA-dependent signaling axis downstream of TGFβ and ErbB2 that requires both the Grb2 and Crk adaptor proteins to increase the migratory and invasive properties of breast cancer cells. In addition, signaling downstream of specific ShcA tyrosine residues facilitates the survival, vascularization, and metastatic spread of breast tumors.

[1]  C. Arteaga,et al.  When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene , 2011, Journal of Mammary Gland Biology and Neoplasia.

[2]  P. Provero,et al.  p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. , 2011, European journal of cell biology.

[3]  T. Pawson,et al.  Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response. , 2010, Cancer research.

[4]  G. Forni,et al.  p130Cas is an essential transducer element in ErbB2 transformation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  L. Deshmukh,et al.  Integrin β3 Phosphorylation Dictates Its Complex with the Shc Phosphotyrosine-binding (PTB) Domain* , 2010, The Journal of Biological Chemistry.

[6]  F. Pépin,et al.  ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties , 2010, PloS one.

[7]  R. Cardiff,et al.  CrkII transgene induces atypical mammary gland development and tumorigenesis. , 2010, The American journal of pathology.

[8]  Michael K. Wendt,et al.  p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-β-mediated Metastasis through Regulation of Smad2/3 Activity* , 2009, The Journal of Biological Chemistry.

[9]  A. Pozzi,et al.  Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. , 2009, Cancer research.

[10]  Carlos L. Arteaga,et al.  Transforming Growth Factor (cid:2) Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab (cid:1) † , 2008 .

[11]  T. Pawson,et al.  ShcA signalling is essential for tumour progression in mouse models of human breast cancer , 2008, The EMBO journal.

[12]  W. Muller,et al.  Signaling through ShcA Is Required for Transforming Growth Factor β- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion , 2008, Molecular and Cellular Biology.

[13]  Jing Qing,et al.  TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .

[14]  J. Fawcett,et al.  Combinatorial ShcA Docking Interactions Support Diversity in Tissue Morphogenesis , 2007, Science.

[15]  J. Trepel,et al.  Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist. , 2007, Cancer research.

[16]  T. Pawson,et al.  Screening for PTB Domain Binding Partners and Ligand Specificity Using Proteome-Derived NPXY Peptide Arrays , 2007, Molecular and Cellular Biology.

[17]  W. Schiemann,et al.  Src phosphorylates Tyr284 in tgf-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion , 2007 .

[18]  D. Sgroi,et al.  p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy , 2006, Breast Cancer Research.

[19]  William P Schiemann,et al.  β3 Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells , 2006, Breast Cancer Research.

[20]  A. Sapino,et al.  p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. , 2006, Cancer research.

[21]  Mingjian Lu,et al.  Dock180-ELMO cooperation in Rac activation. , 2006, Methods in enzymology.

[22]  S. Lowe,et al.  Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.

[23]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[24]  R. Birge,et al.  C‐terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac‐GEF , 2005, Journal of cellular physiology.

[25]  Morag Park,et al.  CrkI and CrkII Function as Key Signaling Integrators for Migration and Invasion of Cancer Cells , 2005, Molecular Cancer Research.

[26]  T. Pawson,et al.  The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Hengartner,et al.  Dock180 and ELMO1 Proteins Cooperate to Promote Evolutionarily Conserved Rac-dependent Cell Migration* , 2004, Journal of Biological Chemistry.

[28]  X. Zang,et al.  KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2 , 2004, Clinical & Experimental Metastasis.

[29]  R. Bagdasaryan,et al.  Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. , 2003, Cancer research.

[30]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[31]  M. Naujokas,et al.  Crk Synergizes with Epidermal Growth Factor for Epithelial Invasion and Morphogenesis and Is Required for the Met Morphogenic Program* , 2002, The Journal of Biological Chemistry.

[32]  M. Naujokas,et al.  Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions. , 2002, Molecular biology of the cell.

[33]  M. Shibuya,et al.  Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules , 2002, Oncogene.

[34]  W. Muller,et al.  Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins* , 2001, The Journal of Biological Chemistry.

[35]  M. Moran,et al.  Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer , 2001, Molecular and Cellular Biology.

[36]  S. Sadekova,et al.  Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor , 2001, Oncogene.

[37]  F. Giancotti,et al.  Tyrosine Phosphorylation of the β4 Integrin Cytoplasmic Domain Mediates Shc Signaling to Extracellular Signal-regulated Kinase and Antagonizes Formation of Hemidesmosomes* , 2001, The Journal of Biological Chemistry.

[38]  T. Pawson,et al.  Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein , 1999, Molecular and Cellular Biology.

[39]  Pier Paolo Pandolfi,et al.  The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.

[40]  R. Cardiff,et al.  Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.

[41]  Tony Pawson,et al.  Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.

[42]  Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.

[43]  M. Shibuya,et al.  Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation , 1997, Molecular and cellular biology.

[44]  M. Shibuya,et al.  A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL‐3. , 1996, The EMBO journal.

[45]  Tony Pawson,et al.  The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein–protein interactions , 1996, Current Biology.

[46]  T. Pawson,et al.  The PTB domain: a new protein module implicated in signal transduction. , 1995, Trends in biochemical sciences.

[47]  T Pawson,et al.  Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. , 1994, Oncogene.

[48]  T. Pawson,et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.

[49]  Sheila M. Thomas,et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.

[50]  T. Pawson,et al.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.